LAG-3 has been shown to be expressed in tumor-infiltrating lymphocytes in a variety of tumor types, including breast, ovarian, and lung cancers, and is commonly associated with increased numbers of PD-1+ T cells (Matsuzaki et al., 2010; Burugu et al., 2017; He et al., 2017). Here, LAG3 is linked to lung carcinoma.